Notably, a study by Ma et al. demonstrated that carnitine palmitoyltransferase 1A (CPT1A) acts collaboratively with L-carnitine derived from tumor-associated macrophages (TAMs) to drive ferroptosis resistance in lung cancer stem cells (CSCs) [9]. The gene discussed is CPT1A; the disease is lung cancer.